Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 58.21% vs 96.31% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 50.08% vs 13.60% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "252.50",
          "val2": "159.60",
          "chgp": "58.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-105.60",
          "val2": "-195.80",
          "chgp": "46.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "8.50",
          "chgp": "-10.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.80",
          "val2": "3.60",
          "chgp": "88.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-96.70",
          "val2": "-193.70",
          "chgp": "50.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-418.30%",
          "val2": "-1,343.10%",
          "chgp": "92.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 122.79% vs 295.27% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 18.22% vs 15.17% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "800.50",
          "val2": "359.30",
          "chgp": "122.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-745.00",
          "val2": "-896.80",
          "chgp": "16.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "31.30",
          "val2": "22.80",
          "chgp": "37.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "25.30",
          "val2": "14.50",
          "chgp": "74.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-768.50",
          "val2": "-939.70",
          "chgp": "18.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,026.30%",
          "val2": "-2,710.00%",
          "chgp": "168.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

252.50

159.60

58.21%

Operating Profit (PBDIT) excl Other Income

-105.60

-195.80

46.07%

Interest

7.60

8.50

-10.59%

Exceptional Items

6.80

3.60

88.89%

Consolidate Net Profit

-96.70

-193.70

50.08%

Operating Profit Margin (Excl OI)

-418.30%

-1,343.10%

92.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 58.21% vs 96.31% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 50.08% vs 13.60% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

800.50

359.30

122.79%

Operating Profit (PBDIT) excl Other Income

-745.00

-896.80

16.93%

Interest

31.30

22.80

37.28%

Exceptional Items

25.30

14.50

74.48%

Consolidate Net Profit

-768.50

-939.70

18.22%

Operating Profit Margin (Excl OI)

-1,026.30%

-2,710.00%

168.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 122.79% vs 295.27% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 18.22% vs 15.17% in Dec 2024

All Annual Results